A post-synaptic-selective 5-HT1A receptor agonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

F-15599

Item No. 46837

Technical Information
Formal Name
(3-chloro-4-fluorophenyl)[4-fluoro-4-[[[(5-methyl-2-pyrimidinyl)methyl]amino]methyl]-1-piperidinyl]-methanone
CAS Number
635323-95-4
Synonyms
  • NLX 101
Molecular Formula
C19H21ClF2N4O
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
O=C(N1CCC(CNCC2=NC=C(C)C=N2)(CC1)F)C3=CC=C(C(Cl)=C3)F
InChi Code
InChI=1S/C19H21ClF2N4O/c1-13-9-24-17(25-10-13)11-23-12-19(22)4-6-26(7-5-19)18(27)14-2-3-16(21)15(20)8-14/h2-3,8-10,23H,4-7,11-12H2,1H3
InChi Key
WAAXKNFGOFTGLP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    F-15599 is a post-synaptic-selective agonist of the serotonin (5-HT) receptor subtype 5-HT1A.1 It more potently stimulates [35S]GTPγS binding to the Gαi subunit in HeLa cell membranes expressing the human 5-HT1A receptor than to the Gαo subunit in rat hippocampal cell membranes (EC50s = 109.7 and 851.1 nM, respectively).2 F-15599 also more potently stimulates [35S]GTPγS binding in rat prefrontal cortex membranes containing postsynaptic 5-HT1A receptors than in rat dorsal raphe nucleus membranes containing presynaptic 5-HT1A receptors (EC50s = 63.1 and 380.2 nM, respectively). It reduces immobility in the forced swim test in rats at a minimal effective dose (MED) of 0.08 mg/kg but induces hypothermia, a sign of serotonin syndrome, at a MED of 0.63 mg/kg.3 F-15599 reduces the incidence of apneas in a transgenic mouse model of Rett syndrome at 0.1 mg/kg and decreases the probability of audiogenic seizure-induced death in a transgenic mouse model of fragile X syndrome at 1.2-2.4 mg/kg.4,5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Maurel, J.L., Autin, J.M., Funes, P., et al. High-efficacy 5-HT1A agonists for antidepressant treatment: A renewed opportunity. J. Med. Chem. 50(20), 5024-5033 (2007).

    2. Newman-Tancredi, A., Martel, J.C., Assié, M.B., et al. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br. J. Pharmacol. 56(2), 338-353 (2009).

    3. Assié, M.B., Bardin, L., Auclair, A.L., et al. 15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity. Int. J. Neuropsychopharmacol. 13(10), 1285-1298 (2010).

    4. Levitt, E.S., Hunnicutt, B.J., Knopp, S.J., et al. A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome. J. Appl. Physiol. 115(11), 1626-1633 (2013).

    5. Tao, X., Newman-Tancredi, A., Varney, M.A., et al. Acute and repeated administration of NLX-101, a selective serotonin-1A receptor biased agonist, reduces audiogenic seizures in developing Fmr1 knockout mice. Neuroscience 509, 113-124 (2023).